7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 
      
    		                        
      nine months
    		                        
      operating activities
    		                        
      net earnings
    		546,000,000 1,143,000,000 563,000,000 662,000,000 568,000,000 725,000,000   510,000,000 522,000,000 224,000,000 458,000,000 -71,000,000 58,000,000 70,000,000 903,000,000 -110,000,000 -91,000,000 304,000,000 945,000,000 28,000,000 -25,000,000 350,000,000 1,018,000,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                        
      depreciation
    		108,000,000 101,000,000 95,000,000 93,000,000 93,000,000 83,000,000   62,000,000 50,000,000 45,000,000 143,000,000 0 1,000,000 46,000,000 127,000,000 -1,000,000 5,000,000 38,000,000 116,000,000 0 -1,000,000 39,000,000 120,000,000 
      amortization of intangible assets
    		156,000,000 149,000,000 158,000,000 145,000,000 130,000,000 112,000,000   89,000,000 58,000,000 49,000,000 138,000,000 3,000,000            
      asset impairments
    		 24,000,000 36,000,000 145,000,000 54,000,000                    
      share-based compensation
    		45,000,000 40,000,000 28,000,000 30,000,000 27,000,000 32,000,000   26,000,000 21,000,000 23,000,000 60,000,000 -3,000,000 -1,000,000 21,000,000 57,000,000 1,000,000 -2,000,000 20,000,000 57,000,000 0 -3,000,000 21,000,000 56,000,000 
      sale of inventory stepped-up to fair value at acquisition
    		                     -9,000,000 12,000,000 125,000,000 
      deferred income tax (benefit) expense
    		-349,000,000                        
      changes in operating assets and liabilities:
    		                        
      accounts receivable
    		-388,000,000 -441,000,000 -393,000,000 -232,000,000 -113,000,000 -439,000,000   -214,000,000 -177,000,000 12,000,000 -24,000,000 -25,000,000 -133,000,000 93,000,000 -146,000,000 75,000,000 -25,000,000 7,000,000 -47,000,000 -46,000,000 121,000,000 -48,000,000 -160,000,000 
      inventories
    		156,000,000 125,000,000 -8,000,000 42,000,000 181,000,000 14,000,000   8,000,000 9,000,000 -42,000,000 -76,000,000 -38,000,000 2,000,000 -61,000,000 -34,000,000 -18,000,000 13,000,000 -38,000,000 28,000,000 -9,000,000 28,000,000 -29,000,000 -133,000,000 
      accounts payable
    		395,000,000 195,000,000 179,000,000 195,000,000 126,000,000 26,000,000   -5,000,000 20,000,000 8,000,000 9,000,000 23,000,000 -49,000,000 30,000,000 2,000,000 20,000,000 -12,000,000 -9,000,000 -27,000,000 -12,000,000 26,000,000 -35,000,000 68,000,000 
      accrued expenses and other liabilities
    		298,000,000 368,000,000 323,000,000 131,000,000 130,000,000 49,000,000   246,000,000 108,000,000 -142,000,000 -87,000,000 122,000,000 -32,000,000 89,000,000 276,000,000 112,000,000 381,000,000 -112,000,000 85,000,000 76,000,000 221,000,000 -202,000,000 148,000,000 
      income taxes
    		120,000,000 65,000,000 24,000,000 95,000,000 -21,000,000 -11,000,000   -132,000,000 -49,000,000 27,000,000 -173,000,000 387,000,000 -25,000,000 -56,000,000 -158,000,000 175,000,000 -132,000,000 -9,000,000 -178,000,000 103,000,000 -41,000,000 -43,000,000 -93,000,000 
      other
    		-120,000,000 -34,000,000 -116,000,000 -68,000,000 -42,000,000 -2,000,000   118,000,000 23,000,000 134,000,000 -87,000,000   -81,000,000 54,000,000 10,000,000 -25,000,000 -11,000,000 -30,000,000 -16,000,000 102,000,000 -74,000,000 -50,000,000 
      net cash from operating activities
    		1,931,000,000 1,528,000,000 1,003,000,000 1,000,000,000 1,237,000,000 735,000,000 -1,563,997,390  648,000,000 671,000,000 380,000,000 1,247,000,000 169,000,000 160,000,000 206,000,000 1,264,000,000 266,000,000 120,000,000 236,000,000 1,088,000,000 112,000,000 422,000,000 35,000,000 988,000,000 
      capex
    		-266,000,000 -145,000,000 -188,000,000 -206,000,000 -165,000,000 -199,000,000 0  -143,000,000 -79,000,000 -46,000,000 -185,000,000 6,000,000 16,000,000 -70,000,000 -152,000,000 4,000,000 2,000,000 -49,000,000 -152,000,000 -7,000,000 1,000,000 -52,000,000 -169,000,000 
      free cash flows
    		1,665,000,000 1,383,000,000 815,000,000 794,000,000 1,072,000,000 536,000,000 -1,563,997,390  505,000,000 592,000,000 334,000,000 1,062,000,000 175,000,000 176,000,000 136,000,000 1,112,000,000 270,000,000 122,000,000 187,000,000 936,000,000 105,000,000 423,000,000 -17,000,000 819,000,000 
      investing activities
    		                        
      acquisitions, net of cash acquired
    		-30,000,000 0 0 -113,000,000 -4,196,000,000 -521,000,000   -36,000,000 -13,000,000 -84,000,000 -548,000,000 -183,000,000 87,000,000 -272,000,000 -2,296,000,000 38,000,000 538,000,000 -600,000,000 -117,000,000 -36,000,000 8,000,000 -9,000,000 -1,922,000,000 
      purchases of marketable securities
    		-17,000,000 -11,000,000 -9,000,000 -11,000,000 -20,000,000 -17,000,000   -15,000,000 -531,000,000 -631,000,000 -3,327,000,000 542,000,000 -563,000,000 -1,017,000,000 -3,398,000,000 683,000,000 -1,070,000,000 -773,000,000 -2,736,000,000 -388,000,000 858,000,000 -1,214,000,000 -5,012,000,000 
      proceeds/(purchases) of short-term investments
    		                        
      proceeds from sales of marketable securities
    		9,000,000 5,000,000 3,000,000 12,000,000 17,000,000 17,000,000    38,000,000 1,087,000,000 2,606,000,000 226,000,000 -204,000,000 1,008,000,000 3,997,000,000 105,000,000 -308,000,000 1,062,000,000 2,697,000,000 -381,000,000 -360,000,000 1,152,000,000 5,399,000,000 
      purchases of property, plant and equipment
    		-266,000,000 -145,000,000 -188,000,000 -206,000,000 -165,000,000 -199,000,000   -143,000,000 -79,000,000 -46,000,000 -185,000,000 6,000,000 16,000,000 -70,000,000 -152,000,000 4,000,000 2,000,000 -49,000,000 -152,000,000 -7,000,000 1,000,000 -52,000,000 -169,000,000 
      proceeds from settlement of net investment hedges
    		0  0                      
      proceeds from the sale of the spinal implants business
    		                        
      other investing
    		1,000,000 -1,000,000 32,000,000 4,000,000 12,000,000    1,000,000                
      net cash from investing activities
    		-303,000,000 -152,000,000 -162,000,000 -314,000,000 -4,352,000,000 -719,000,000 1,228,997,143 1,152,998,387 -177,000,000 -585,000,000 326,000,000 -1,454,000,000 591,000,000 -664,000,000 -351,000,000 -1,849,000,000 830,000,000 -838,000,000 -360,000,000 -308,000,000 -812,000,000 507,000,000 -123,000,000 -1,638,000,000 
      financing activities
    		                        
      proceeds (payments) on short-term borrowings
    		0 0                       
      proceeds from issuance of long-term debt
    		0  0 0 999,000,000                   0 
      payments on long-term debt
    		-1,438,000,000 -1,206,000,000 -151,000,000 0 -1,797,000,000 -1,000,000                   
      payments of dividends
    		-305,000,000 -285,000,000 -263,000,000 -237,000,000                     
      cash paid for taxes from withheld shares
    		-49,000,000 -34,000,000 -33,000,000 -26,000,000 -31,000,000 -6,000,000                   
      other financing
    		-2,000,000 -2,000,000 0 -11,000,000 -3,000,000 -79,000,000   1,000,000 -4,000,000 27,000,000              
      net cash from financing activities
    		-1,794,000,000 -286,000,000 -446,000,000 -288,000,000 -1,057,000,000 2,363,000,000 951,001,329 521,999,206 -42,000,000 161,000,000 -734,000,000 696,000,000 -655,000,000 402,000,000 186,000,000 405,000,000 -12,000,000 -744,000,000 651,000,000 -339,000,000 38,000,000 -20,000,000 -128,000,000 -549,000,000 
      effect of exchange rate changes on cash and cash equivalents
    		-32,000,000 21,000,000 29,000,000 -17,000,000 32,000,000 10,000,000   -66,000,000 -31,000,000 -93,000,000 -70,000,000 -6,000,000 -2,000,000 1,000,000 -15,000,000 -3,000,000 2,000,000 -9,000,000 19,000,000 -11,000,000 9,000,000 1,000,000 33,000,000 
      change in cash and cash equivalents
    		-198,000,000 1,111,000,000 424,000,000 381,000,000 -4,140,000,000 2,389,000,000 624,001,074 723,999,226 363,000,000 216,000,000 -121,000,000 419,000,000 99,000,000 -104,000,000 42,000,000 -195,000,000 1,081,000,000 -1,460,000,000 518,000,000 460,000,000 -673,000,000    
      cash and cash equivalents at beginning of period
    		                        
      cash and cash equivalents at end of period
    		                        
      six months
    		                        
      proceeds from maturity of short-term investments
    		                        
      three months
    		                        
      goodwill and other impairments
    		                        
      sale of inventory stepped up to fair value at acquisition
    		        -1,000,000 0 7,000,000 17,000,000 1,000,000 4,000,000 5,000,000 20,000,000 0        
      purchase of short-term investments
    		                        
      cash and cash equivalents at beginning of year
    		         0               
      cash and cash equivalents at end of year
    		         216,000,000               
      supplemental cash flow disclosure:
    		                        
      cash paid for income taxes, net of refunds
    		                        
      cash paid for interest on debt
    		                        
      purchases of short-term investments
    		                        
      goodwill impairment
    		                        
      recall charges
    		 6,000,000 -29,000,000 5,000,000 21,000,000 13,000,000   54,000,000                
      recall-related payments
    		 -7,000,000 -131,000,000 -41,000,000 -4,000,000 -5,000,000   -62,000,000 -34,000,000               
      proceeds and payments on short-term borrowings
    		                        
      repurchases of common stock
    		     0                   
      dividends paid
    		    -216,000,000 -193,000,000   -142,000,000 -130,000,000 -131,000,000 -347,000,000 1,000,000 -1,000,000 -115,000,000 -301,000,000 0 1,000,000 -101,000,000 -243,000,000 0 0 -81,000,000 -209,000,000 
      payments to purchase noncontrolling interest
    		                        
      effect of exchange rate changes
    		                        
      payments on short-term borrowings
    		                        
      (payments) proceeds on short-term borrowings
    		                        
      proceeds from borrowings
    		        -3,154,000,000 278,000,000 581,000,000 1,206,000,000 -1,074,000,000 1,125,000,000 344,000,000 259,000,000 8,000,000 -958,000,000 1,060,000,000 141,000,000 -13,000,000 6,000,000 44,000,000 139,000,000 
      payments on borrowings
    		        -205,000,000 -473,000,000 -1,081,000,000 -1,135,000,000 372,000,000 -610,000,000 -55,000,000 -248,000,000 -7,000,000 -49,000,000 -51,000,000 -146,000,000 19,000,000 -17,000,000 -38,000,000 -167,000,000 
      net cash from operations activities
    		                        
      recall-related payments, net of insurance recovery
    		                        
      deferred income tax benefit
    		                        
      excess income tax benefits from stock issued under employee stock plans
    		        -5,000,000                
      repurchase of common stock
    		        0                
      sales of marketable securities
    		                        
      gross recall charges
    		         33,000,000 54,000,000              
      excess tax benefits from stock issued under employee stock plans
    		                        
      changes in operating assets and liabilities, net of effects of acquisitions:
    		                        
      repurchase and retirement of common stock
    		          -130,000,000 -60,000,000 20,000,000   -315,000,000   -250,000,000 -89,000,000 20,000,000 11,000,000 -50,000,000 -333,000,000 
      recall related payments
    		          -19,000,000              
      restructuring charges
    		            -1,000,000 0 5,000,000 36,000,000 4,000,000 -4,000,000 14,000,000 63,000,000 -7,000,000 5,000,000 14,000,000  
      recall accruals
    		            -223,000,000            
      intangible asset amortization
    		              45,000,000 104,000,000 -2,000,000        
      proceeds from sales of property, plant and equipment
    		                       66,000,000 
      intangibles amortization
    		                  32,000,000      
      property, plant and equipment impairment
    		                        
      deferred income tax credit
    		                        
      amortization
    		                    -1,000,000 -1,000,000 84,000,000 237,000,000 
      loaner instrumentation
    		                    -1,000,000 -1,000,000 -54,000,000 -169,000,000 
      decrease in cash and cash equivalents
    		                      -215,000,000  
      payments of restructuring charges
    		                        
      increase in cash and cash equivalents
    		                       -1,166,000,000 
      income tax benefit from exercise of stock options
    		                        
      excess income tax benefit from exercise of stock options
    		                        
      payment of restructuring charges
    		                        
      (gain) loss on sale of property, plant and equipment
    		                        
      issuance cost of long-term debt
    		                        
      proceeds from exercise of stock options
    		                        
      adjustments to reconcile net earnings from continuing operations to net cash from operating activities:
    		                        
      benefit from losses on accounts receivable
    		                        
      less: net earnings from discontinued operations
    		                        
      less: net gain on sale of discontinued operations
    		                        
      net earnings from continuing operations
    		                        
      intangible asset impairment
    		                        
      net cash from discontinued operations
    		                        
      proceeds from sale of discontinued operations, net of cash divested
    		                        
      net cash used by discontinued operations
    		                        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.